Stockreport

Omeros Initiates Dosing in Phase 1 Clinical Trial for OMS527 Targeting Addiction

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF -- Nicotine Addiction Planned as First Indication -- SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (NASDAQ: OMER) today announced that the [Read more]